Research Staff
Tracey A. Ignatowski, Ph.D.
Dr. Ignatowski is the Director of Research and Development at NanoAxis, LLC. She has over 12 years of experience in neuroimmunology, pathology, and pharmacology research using both cellular and whole animal paradigms. Dr. Ignatowski received her Ph.D. in 1995 from the University at Buffalo-SUNY, School of Medicine and Biomedical Sciences, Department of Pathology and completed a Post-doctoral Fellowship at the University of Rochester Medical Center, Department of Pharmacology and Physiology from 1995 to 1997. In 1997, Dr. Ignatowski was appointed as Research Assistant Professor in the Department of Pathology (with a secondary appointment in Anesthesiology) at the University at Buffalo. She remains actively engaged in research pertaining to elucidating mechanisms involved in cytokine regulation of neurotransmitter release in the brain, determining cytokine localization in the brain, and demonstrating brain-associated cytokine regulation of peripheral macrophage functioning. She has authored more than 30 publications and two book chapters in this field. She currently carries out and directs research at NanoAxis focusing on using NanoAxis proprietary patent pending nanomaterials for various neurological disease processes.
Dr. Ignatowski is the Director of Research and Development at NanoAxis, LLC. She has over 12 years of experience in neuroimmunology, pathology, and pharmacology research using both cellular and whole animal paradigms. Dr. Ignatowski received her Ph.D. in 1995 from the University at Buffalo-SUNY, School of Medicine and Biomedical Sciences, Department of Pathology and completed a Post-doctoral Fellowship at the University of Rochester Medical Center, Department of Pharmacology and Physiology from 1995 to 1997. In 1997, Dr. Ignatowski was appointed as Research Assistant Professor in the Department of Pathology (with a secondary appointment in Anesthesiology) at the University at Buffalo. She remains actively engaged in research pertaining to elucidating mechanisms involved in cytokine regulation of neurotransmitter release in the brain, determining cytokine localization in the brain, and demonstrating brain-associated cytokine regulation of peripheral macrophage functioning. She has authored more than 30 publications and two book chapters in this field. She currently carries out and directs research at NanoAxis focusing on using NanoAxis proprietary patent pending nanomaterials for various neurological disease processes.
Robert N. Spengler, Ph.D.
Dr. Spengler is the Director of Research and Development at NanoAxis, LLC. He has over 20 years of experience in neurobiology, pharmacology, and molecular immunology. Dr. Spengler received his Ph.D. in 1987 from the University of Michigan, Ann Arbor (Department of Pharmacology) where he studied the regulation and function of the ?2-adrenergic receptor in the central nervous system. After a two-year Post-doctoral Fellowship in the immunopathology laboratory of Dr. Steven L. Kunkel at the University of Michigan, where he studied adrenergic and prostaglandin regulation of TNF production by macrophage, he became an Assistant Professor, Department of Pathology, University at Buffalo-SUNY with a secondary appointment in the Department of Anesthesiology. In 1999, he was promoted to Associate Professor of Pathology. He remained at the University at Buffalo in this capacity until 2005. Dr. Spengler's current and past research interests have focused on how cytokines and neurotransmitters are interrelated as they regulate both the neuron and the white blood cell. He has published over 50 manuscripts and has authored four book chapters. Dr. Spengler is an instrumental component of directing and advancing our patent pending nanomaterials for use in various neurological disease processes.
Dr. Spengler is the Director of Research and Development at NanoAxis, LLC. He has over 20 years of experience in neurobiology, pharmacology, and molecular immunology. Dr. Spengler received his Ph.D. in 1987 from the University of Michigan, Ann Arbor (Department of Pharmacology) where he studied the regulation and function of the ?2-adrenergic receptor in the central nervous system. After a two-year Post-doctoral Fellowship in the immunopathology laboratory of Dr. Steven L. Kunkel at the University of Michigan, where he studied adrenergic and prostaglandin regulation of TNF production by macrophage, he became an Assistant Professor, Department of Pathology, University at Buffalo-SUNY with a secondary appointment in the Department of Anesthesiology. In 1999, he was promoted to Associate Professor of Pathology. He remained at the University at Buffalo in this capacity until 2005. Dr. Spengler's current and past research interests have focused on how cytokines and neurotransmitters are interrelated as they regulate both the neuron and the white blood cell. He has published over 50 manuscripts and has authored four book chapters. Dr. Spengler is an instrumental component of directing and advancing our patent pending nanomaterials for use in various neurological disease processes.